Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV.
2024 Funding Opportunities
A Momentum funding round providing grants of up to £300,000 over three years will be launched in quarter one 2024. The focus of this funding round will be to increase access to harm reduction services for people who use drugs. (closed)
An Innovator funding round providing grants of up to £100,000 over two years will be launched in quarter two 2024. The focus of this funding round will be to work towards ending Paediatric AIDS. (closed)
An Innovator funding round providing grants of up to £100,000 over two years will be launched in quarter two. The focus of this funding round will be to eliminate HIV stigma.
Pease note, the Positive Action funding round plan is subject to change.
Introduction To Positive Action Funding
Through its Community Strategic Initiatives, Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV. We currently offer funding under two funding streams, Innovator Funding, that aims to test and pilot new ways of working, and Momentum Funding, that aims to scale-up proven ways of working.
Innovator Funding
Up to £100,000 over two years (£50,000 per year)
- Investments into the testing and piloting of new approaches
- The proposed approach(es) must be new to the funding applicant but can have been delivered by another organisation in a different location or aimed at a different target population.
A two 2- year pilot that aims to build evidence before scale-up
Momentum Funding
- Up to £300,000 over three years (£ 100,000 per year)
- Advancing existing, evidence-based projects to enable sustainable scale-up
- The funding applicant must have delivered the approach(es) previously and have evidence that the approach(es) work
- Funding can be used to build on previous investments made by Positive Action or other donors
A three-year scale-up aimed at advancing previous projects with a focus on sustaining interventions beyond the three-year Positive Action investment
NP-GBL-HVX-COCO-220063 | April 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
